3646 results for «574»

Filter By

3646 results

Complications: stable CAD & other coronary interventions

12 May 2021 – From EuroPCR 2021

Have a look at this session if you wish to learn how to handle right coronary artery perforation in a calcified vessel, analyze barotrauma-induced perforation, discover an innovative technique to seal distal wire perforation, and more!

EuroPCR 2021 Complications: stable CAD & other coronary interventions

EAPCI-PCR Fellows Course 2021 - Coronary track: Ambiguous LM/PCI strategy for mid-LAD bifurcation

14 Apr 2021 – From EuroPCR 2021

The best PCI strategies for an ambiguous LM, then a mid-LAD bifurcation. With golden tips from G. Stankovic and T. Lefèvre!

The EAPCI-PCR Fellows Course is a project supported by the New Initiatives For Young Interventionalists Committee (NIFYI) and PCR NextGen, and is intended for practitioners at...

EAPCI-PCR Fellows Course 2021 - Coronary track: Ambiguous LM/PCI strategy for mid-LAD bifurcation

EuroPCR 2021 - Innovations in TAVI

18 May 2021 – From EuroPCR 2021

In this session, find out more about an innovative active sealing cuff providing a new strategy to mitigate PVL, post-implantation CT scans to print patient-specific 3D models, transcatheter antiembolic filter, and much more!

EuroPCR 2021 - Innovations in TAVI

Challenging Left Main Cases

18 May 2021 – From EuroPCR 2021

Watch this session to learn how to treat a challenging LM case in a young patient, to question the need to treat residual LAD disease after PPCI for an inferior STEMI, to find out more about complex left main bifurcation PCI with OCT control, and to...

Challenging Left Main Cases

TRISCEND II: Two-year outcomes of transcatheter tricuspid valve replacement for severe tricuspid regurgitation

31 Mar 2026

Jonathan Curio provides his take on TRISCEND II trial results presented by Vinod H. Thourani at ACC.26 in New Orleans.

Jonathan Curio

Author

Jonathan Curio
TRISCEND II: Two-Year Outcomes Of Transcatheter Tricuspid Valve Replacement For Severe Tricuspid Regurgitation

ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation

31 Aug 2021

Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.

Daniele Giacoppo

Author

Daniele Giacoppo
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation
Didn’t find what you were looking for?